Incidence and survival rates for female malignant germ cell tumors

Obstetrics and Gynecology
Harriet O SmithClifford R Qualls

Abstract

To evaluate 30-year, population-based trends in incidence and survival rates for malignant germ cell tumors originating within the female genital tract. Surveillance, Epidemiology, and End Results data were used to identify malignant germ cell tumors (1973-2002). Overall and 5-year incidence rates, estimated annual percentage change, and survival rates were calculated and compared by age at diagnosis, race, stage, and histology. Of 1,262 cases, there were 414 (32.8%) dysgerminomas, 449 (35.6%) immature teratomas, 37 (2.9%) mature teratomas with malignant degeneration, and 362 (28.7%) mixed germ cell tumors. The 30-year, age-adjusted incidence rate per 100,000 women-years was 0.338, decreasing by 29.4% for dysgerminomas (P = .18) and by 31.5% for mixed germ cell tumors (P = .22). Other nonwhites had higher rates than whites and blacks, but dysgerminoma rates were higher in whites and other nonwhites than in blacks. Using the registries for expanded races, rates were higher for Asian/Pacific Islanders (P = .059) and Hispanics (P = .07). By age at diagnosis, 15-19 year olds had the highest rates and the only significant change in rates (37.5% increase, P = .008). The 5-year relative survival was 83.9%. Survival rates improved sign...Continue Reading

References

Jan 1, 1991·Journal of Clinical Epidemiology·E J FeuerD T Green
Dec 1, 1987·Psychological Reports·N Breslow
Jan 1, 1987·Annual Review of Public Health·L Breslow
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J FeuerB S Kramer
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S WilliamsP Hanjani
Jan 6, 1993·Journal of the National Cancer Institute·C R NicholsL H Einhorn
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Bokemeyer, H J Schmoll
Jan 1, 1995·Cancer·F D Gilliland, C R Key
Jun 5, 1996·Journal of the National Cancer Institute·R BergströmT Hakulinen
Feb 1, 1997·Current Opinion in Obstetrics & Gynecology·A Talerman
Nov 5, 1997·Journal of the National Cancer Institute·L B TravisJ D Boice
Jun 2, 1998·Medical and Pediatric Oncology·U GöbelD Harms
Jul 7, 1999·The Journal of Hospital Infection·R Cunningham
Oct 16, 1999·International Journal of Cancer. Journal International Du Cancer·I dos Santos SilvaA Reid
Jan 15, 2000·Obstetrics and Gynecology·K TewariM F Kohler
Jul 5, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S WeissA L Kaplan
Dec 20, 2002·Cancer·Katherine A McGlynnRobert E Tarone
May 20, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Henrik Møller, Helen Evans
Jun 26, 2003·Cancer Science·Akiko IokaAkira Oshima
Sep 16, 2003·Clinical Obstetrics and Gynecology·Harriet O Smith
Dec 16, 2003·Obstetrics and Gynecology·Harriet O SmithCharles R Key
Jan 31, 2004·Pediatric Blood & Cancer·Dominik T SchneiderUlrich Göbel
Mar 16, 2004·Journal of Pediatric Surgery·D BillmireUNKNOWN Children's Oncology Group (COG)

❮ Previous
Next ❯

Citations

May 14, 2011·Pediatric Radiology·Monica EpelmanSabah Servaes
Mar 13, 2012·Medical Oncology·Hamed A L HusainiIsmail A Al-Badawi
Apr 15, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T de La Motte RougeC Lhommé
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO Guidelines Working Group
Feb 20, 2010·Neuro-oncology·J Lee VillanoBridget J McCarthy
Oct 8, 2009·Current Opinion in Obstetrics & Gynecology·Vânia Gonçalves
Jul 29, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giorgia MangiliDomenica Lorusso
Jul 29, 2009·Journal of Pediatric Hematology/oncology·Tress L GoodwinPaul Graham Fisher
Sep 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·X L DuS Fang
May 2, 2013·Experimental Hematology & Oncology·Maria Carmo Pereira NunesTeresa Cristina Abreu Ferrari
Sep 25, 2009·Endocrine Reviews·Mark A EdsonMartin M Matzuk
Apr 25, 2012·AJR. American Journal of Roentgenology·Evelyn Y AnthonyMichael Y M Chen
Mar 1, 2014·Archives of Pathology & Laboratory Medicine·Francisco F NogalesOvidiu Preda
May 27, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O SolheimS D Fosså
May 14, 2014·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Akram M ShaabanChristine O Menias
Feb 18, 2016·Journal of Cancer Survivorship : Research and Practice·D Ahmed-Lecheheb, F Joly
Jan 17, 2016·Gynecologic Oncology·Emily HinchcliffJohn Schorge
Jun 16, 2015·Gynecologic Oncology Reports·Wen XuCatherine Shannon
Oct 20, 2010·Journal of Minimally Invasive Gynecology·Camran NezhatMichael Lewis
Sep 28, 2010·Journal of Pediatric and Adolescent Gynecology·Natalie Catharine Moniaga, Leslie M Randall
Jun 1, 2010·Maturitas·Pakhee Aggarwal, Sean Kehoe
Jan 26, 2010·Gynecologic Oncology·Danielle VicusHelen Mackay
Jun 30, 2009·Gynecologic Oncology·Christopher S BryantRobert T Morris
Feb 24, 2009·Journal of Pediatric and Adolescent Gynecology·Akihiro TakedaHiromi Nakamura
Feb 12, 2008·Journal of Minimally Invasive Gynecology·Stefano UccellaFabio Ghezzi
Mar 3, 2007·Cancer Treatment Reviews·Charles A Stiller
Sep 4, 2008·International Journal of Cancer. Journal International Du Cancer·Jay P ShahRobert T Morris
Jun 20, 2008·Journal of Surgical Oncology·John K ChanDaniel S Kapp
Feb 10, 2011·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·S GuerrieroL Valentin
Apr 1, 2009·Seminars in Oncology·Carolyn R Koulouris, Richard T Penson
Jul 23, 2008·Gynecologic Oncology·David M Gershenson
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Qiong-Lan TangLin Xue
Jun 28, 2015·Gynecologic Oncology·Jane L MeiselDarren R Feldman
Jul 19, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Jessica OttolinaMassimo Candiani
Jul 26, 2014·Cancer Causes & Control : CCC·Satu-Liisa PauniahoMarkku Heikinheimo
Apr 7, 2015·Gynecologic Oncology·Jeong-Yeol ParkJoo-Hyun Nam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David M Gershenson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
N MurugaesuM J Seckl
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Daniel M PattersonGordon J S Rustin
© 2022 Meta ULC. All rights reserved